These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36636067)

  • 1. Prognostic value of nicotinamide adenine dinucleotide (NAD
    Cai L; Ke C; Lin Z; Huang Y; Wang A; Wang S; Chen C; Zhong C; Fu L; Hu P; Chai J; Zhang H; Zhang B
    J Gastrointest Oncol; 2022 Dec; 13(6):2845-2862. PubMed ID: 36636067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
    Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
    Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
    Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
    Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of NAD+ metabolism-related biomarkers in patients with diabetic peripheral neuropathy.
    Ye C; Fu Y; Zhou X; Zhou F; Zhu X; Chen Y
    Front Endocrinol (Lausanne); 2024; 15():1309917. PubMed ID: 38464965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune infiltration and prognosis in gastric cancer: role of NAD+ metabolism-related markers.
    Xing Y; Zhang Z; Gao W; Song W; Li T
    PeerJ; 2024; 12():e17833. PubMed ID: 39099656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
    Chen Z; Cheng G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):666-680. PubMed ID: 37691229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study.
    Zhu W; Fu M; Li Q; Chen X; Liu Y; Li X; Luo N; Tang W; Zhang Q; Yang F; Chen Z; Zhang Y; Peng B; Zhang Q; Zhang Y; Peng X; Hu G
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113253. PubMed ID: 39353384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of prognostic indicator based on NAD+ metabolism related genes in glioma.
    Chen X; Wu W; Wang Y; Zhang B; Zhou H; Xiang J; Li X; Yu H; Bai X; Xie W; Lian M; Wang M; Wang J
    Front Surg; 2023; 10():1071259. PubMed ID: 36778644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics.
    He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H
    PeerJ; 2024; 12():e16951. PubMed ID: 38436027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 13. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
    Li X; Lei Y
    Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
    Qiu H; Zhang X; Yu H; Gao R; Shi J; Shen T
    Bioengineered; 2021 Dec; 12(1):4304-4319. PubMed ID: 34348580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of
    Yicheng F; Xin L; Tian Y; Huilin L
    Front Genet; 2022; 13():808542. PubMed ID: 36046250
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of NAD
    Lin L; Chen L; Xie Z; Chen J; Li L; Lin A
    Front Genet; 2022; 13():905238. PubMed ID: 35783253
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
    Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
    Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
    Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
    Front Oncol; 2021; 11():612952. PubMed ID: 34235071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma.
    Lin Y; Zhang Z; Li Y; Chen Y; Su M; Zhao W
    Medicine (Baltimore); 2022 Nov; 101(46):e31839. PubMed ID: 36401393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.